⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3479455 | 0.79 | TSHR (0.42) | — | |
| SCHEMBL3070404 | 0.75 | — | — | |
| SCHEMBL3688126 | 0.75 | TRPA1 (0.38) | — | |
| SCHEMBL328997 | 0.75 | TSHR (0.35) | — | |
| SCHEMBL9640215 | 0.73 | — | — | |
| SCHEMBL416404 | 0.73 | — | — | |
| SCHEMBL7365551 | 0.72 | — | — | |
| SCHEMBL3279404 | 0.72 | — | — | |
| SCHEMBL282934 | 0.71 | — | — | |
| SCHEMBL282935 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7723470-B2 | Glycopeptide derivatives and pharmaceutical compositions containing the same | THERAVANCE, INC. (US) | 2010-05-25 | — | — | US | disclosed |
| US-20080103292-A1 | Glycopeptide derivatives and pharmaceutical compositions containing the same | CUMBERLAND PHARMACEUTICALS INC. | 2008-05-01 | — | — | US | disclosed |
| EP-1487863-A4 | PROCESS FOR PURIFYING GLYCOPEPTIDE PHOSPOHONATE DERIVATIVES | THERAVANCE INC (US) | 2007-08-29 | — | — | EP | disclosed |
| EP-1487863-A2 | PROCESS FOR PURIFYING GLYCOPEPTIDE PHOSPOHONATE DERIVATIVES | Theravance, Inc. (US) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003018608-A2 | PROCESS FOR PURIFYING GLYCOPEPTIDE PHOSPHONATE DERIVATIVES | THERAVANCE, INC. (US) | 2003-03-06 | — | — | WO | disclosed |
| EP-1102597-A1 | MULTIVALENT AGONISTS, PARTIAL AGONISTS, INVERSE AGONISTS AND ANTAGONISTS OF THE 5HT 4 RECEPTORS | Advanced Medicine, Inc. (US) | 2001-05-30 | — | — | EP | disclosed |
| WO-1999064055-A1 | MULTIVALENT AGONISTS, PARTIAL AGONISTS, INVERSE AGONISTS AND ANTAGONISTS OF THE 5HT4 RECEPTORS | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |